Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide
This study has been terminated.
( Closed for lack of enrollment )
Study NCT00041574 Information provided by INO Therapeutics
First Received: July 10, 2002 Last Updated: January 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pulmonary Hypertension
Lung Disease
Sickle Cell Disease
Cardiac Transplant
Lung Transplant
Additional conditions recognized in this trial
Anemia, Sickle Cell
Hypertension
Hypertension, Pulmonary
Lung Diseases
Pulmonary Heart Disease
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Cardiovascular Diseases
Genetic Diseases, Inborn
Heart Diseases
Hematologic Diseases
Hemoglobinopathies
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
Inhaled Nitric Oxide
Additional drug interventions recognized in this trial
Nitric Oxide
More general drug interventions related to this trial
Anti-Asthmatic Agents
Antioxidants
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Endothelium-Dependent Relaxing Factors
Free Radical Scavengers
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
INO Therapeutics
Back to top of Main Content
